PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support

PeerCurrent

PcPeerCurrent

Your Feed AI Summary Saved Board Expert Discussion This Week in Your Field

Follows Journals Trials Guidelines Markets

Set your cadence Alerts Settings Help

Back to follows

Researcher

Paulo Genitiano

The University of Texas MD Anderson Cancer Center

1 development in the corpus

Following this puts new work involving it at the top of your briefing, with a note saying why it is there. Links are taken from the source record, never inferred.

For You Latest Breakthroughs Trials Reviews Guidelines

Latest

Everything in the corpus, newest first.

AUG 10, 2026 · JOURNAL ARTICLE

Combination treatment with intravesical interferon-alpha gene therapy and an oral pan-ErbB receptor family blocker improves survival in mice with bladder cancer

Frontiers in Molecular Biosciences

Preclinical murine model study identifying a putative resistance mechanism and demonstrating proof-of-concept for combination therapy, but requiring clinical translation and validation.

Hypothesis-GeneratingAkshay Sood Mikael Rauf Bladder and Urothelial Cancer Treatments

Reported

Median overall survival, LV-IFNα/…49 days

Median overall survival, Control…15 days

Median overall survival, LV-Ctrl…14 days

PeerCurrent.com|Stay current with the people and research shaping what comes next.

About Privacy Terms Support